期刊文献+

鲍曼不动杆菌和肺炎克雷伯菌对替加环素体外敏感性检测的方法学评估 被引量:1

Comparison of different susceptibility testing methods of tigecycline against Acinetobacter baumannii and Klebsiella pneumoniae
原文传递
导出
摘要 目的 评估不同药敏试验方法检测鲍曼不动杆菌和肺炎克雷伯菌对替加环素的体外药敏结果。方法 连续收集2012年1月至3月临床感染患者分离的50株耐碳青霉烯类鲍曼不动杆菌(CRAB)和49株肺炎克雷伯菌,采用微量肉汤稀释法、Vitek-2法、MIC Test Strip(MTS)法及纸片扩散法分别测定替加环素对两种细菌的敏感性,并以微量肉汤稀释法为参考方法,评估Vitek-2法、MTS法及纸片扩散法与参考方法的一致性。结果 按照美国食品药品监督局(FDA)的判断标准,微量肉汤稀释法、Vitek-2法和MTS法检测替加环素对CRAB和肺炎克雷伯菌的敏感性分别为94.0%/91.8%,68.0%/91.8%和90.0%/91.8%。对于CRAB,Vitek-2法和MTS法与参考方法的基本一致率/分类一致率(EA/CA)分别为94.0%/72.0%和92.0%/90.0%,66.0% (33/50)的菌株Vitek-2法检测的MIC值比参考方法高1~2个稀释度,MTS法检测的MIC值存在32.0% (16/50)偏高及22.0% (11/50)偏低;对于肺炎克雷伯菌,Vitek-2法和MTS法与参考方法的EA/CA分别为95.9%/98.0%和83.7%/91.8%,36.7% (18/49)的菌株Vitek-2法检测的MIC值比参考方法低1~3个稀释度,79.6%(39/49)的菌株MTS检测的MIC值比参考方法低1~3个稀释度。Vitek-2法和MTS法检测两种细菌均未出现重大误差(VME)和大误差(ME)。纸片扩散法与参考方法相比,对于CRAB,采用敏感/耐药(≥14 mm/≤10 mm)折点,CA为94.0%,高于Jones等推荐的折点(≥16 mm/≤12 mm,CA为82.0%);对肺炎克雷伯菌,采用敏感/耐药(≥14 mm/≤10 mm)折点,CA为93.9%,高于FDA中肠杆菌的折点(≥19 mm/≤14 mm,CA为67.3%)。结论 对于CRAB菌株,MTS法与微量肉汤稀释法的一致性较高,MIC结果存在一定程度的偏差;对于肺炎克雷伯菌,Vitek-2法与微量肉汤稀释法的一致性较高,MIC结果存在一定程度的偏低;纸片扩散法与微量肉汤稀释法一致性较低,针对不同细菌其判定折点需进一步研究。 Objective To compare different susceptibility testing methods of tigecycline against Acinetobacter baumannii and Klebsiella pneumoniae.Methods Fifty carbapenem-resietant A.baumannii (CRAB) strains and 49 K.pneumoniae strains were collected from Tianjin Medical University General Hospital during January and March 2012.Minimum inhibitory concentration (MIC) and inhibitory zone diameters for tigecycline were determined by broth microdilution,Vitek-2,MTS and disk diffusion methods.The results of Vitek-2,MTS and disk diffusion methods were compared with those of broth microdilution method.Results According to FDA standards,the susceptibilities of CRAB and K.pneumoniae to tigecycline determined by broth microdilution,Vitek-2 and MTS were 94.0%/91.8%,68.0%/91.8% and 90.0%/91.8%,respectively.For CRAB isolates,the essential agreement (EA) and categorical agreement (CA) produced by Vitek-2 and MTS were 94.0%/72.0% and 92.0%/90.0%.MICs determined by Vitek-2 were 1-2 dilutions higher than the reference method in 33 (66.0%) strains,and those determined by MTS were higher in 16 (32.0%) strains and lower in 11 (22.0%) strains.For K.pneumoniae isolates,the EA/CA produced by Vitek-2 and MTS were 95.9%/98.0% and 83.7%/91.8%,respectively.MICs determined by Vitek-2 were 1-3 dilutions lower than the reference method in 17 (34.7%) strains,and those determined by MTS were 1-3 dilutions lower than the reference method in 39 (79.6%) strains.None of thetwo methods produced very major error (VME) and major error (ME) against two kinds of isolates.The results were determined by disk diffusion method using different breakpoints according different isolates.For CRAB,using ≥14 mm/≤ 10 mm as breakpoint,CA was 94.0%,which was higher than the breakpoint recommended by Jones et al (≥16 mm/≤12 mm,CA was 82.0%) ; and for K.pneumoniae,using the ≥ 14 mm/≤ 10 mm as breakpoint,CA was 93.9%,higher than the FDA Enterobacteriaceae breakpoint (≥ 19 mm/≤ 14 mm,CA was 67.3%).Conclusion For CRAB str
出处 《中华临床感染病杂志》 CAS 2013年第5期282-286,共5页 Chinese Journal of Clinical Infectious Diseases
  • 相关文献

参考文献14

二级参考文献81

  • 1Petersen PJ, Jacobus NV, Weiss WJ, et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother, 1999, 43:738-744. 被引量:1
  • 2Bradford P. Tigecycline: a first in class glycylcycline. Clin Micro Newsl, 2004,26:163-168. 被引量:1
  • 3Felmingham D. Tigecycline-the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline. J Chemother, 2005,17 Suppl 1:5-11. 被引量:1
  • 4Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother,1992 ,29 :245-277. 被引量:1
  • 5Schnappinger D, Hillen W. Tetraeyclines: antibiotic action, uptake, and resistance mechanisms. Arch Mierobiol, 1996, 165:359-369. 被引量:1
  • 6Bauer G, Berens C, Projan SJ, et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drugdirected Fe^2 + cleavage of 16S rRNA. J Antimicrob Chemother, 2004, 53:592-599. 被引量:1
  • 7Olson MW, Ruzin A, Feyfant E, et al. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother, 2006,50 : 2156 -2166. 被引量:1
  • 8Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Mierob Drug Resist, 2007,13:1-6. 被引量:1
  • 9Ruzin A, Visalli MA, Keeney D, et al. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother,2005,49 : 1017-1022. 被引量:1
  • 10Visalli MA, Murphy E, Projan SJ, et al. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline ( GAR- 936) in Proteus mirabilis. Antimicrob Agents Chemother. 2003.47,665-669. 被引量:1

共引文献255

同被引文献10

  • 1Clinical and Laboratory Standards Institute. M23-A3 Development of in vitro susceptibility testing criteria and quality control parameters : approved guideline[S]. Wayne, PA: CLSI, 2008. 被引量:1
  • 2Navon-Venezia S, Leavitt A, Canneli Y. High tigecycline resistance in multidrug-resistant Acinetobaeter baumannii[J]. J Antimierob Chemother, 2007,59(4):772. 被引量:1
  • 3Pillar C M, Draghi D C, Dowzicky M J, et al. In vitro activity of tigecycline aghinst gram-positive and gram-negative pathogens as evaluated by broth microdilution and E test [J]. J Clin Microbiol, 2008,46(9):2862. 被引量:1
  • 4Zarkotou O, Pournaras S, Altouvas G, et al. Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and earbapenem-resistant gram-negative , pathogens[J]. J Clin Mierobiol, 2012,50(11):3747. 被引量:1
  • 5Liu J W, Ko W C, Huang C H, et al. Agreement assessment of tigeeyeline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010[J]. Antimicrob Agents Chemother, 2012,56(3):1414. 被引量:1
  • 6Huang T D, Berhin C, Bogaerts P, et al. In vitro susceptibility of multidrug -resistant Enterubacteriaceae clinical isolates . to tigecycline[J]. J Antimicrob Chemother, 2012,67(11):2696. 被引量:1
  • 7Sader H S, Flamm R K, Jones R/N. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)[J]. Diagn Microbiol Infect Dis, 2013,76(2):217. 被引量:1
  • 8王辉,俞云松,王明贵,倪语星,马越,任健康,韩锟,卓超,徐英春,胡云建,胡志东,曹彬,罗燕萍,褚云卓,廖康,康梅,张冀霞.替加环素体外药敏试验操作规程专家共识[J].中华检验医学杂志,2013,36(7):584-587. 被引量:134
  • 9杜小幸,王海萍,傅鹰,陈衍,俞云松.不同药敏方法检测替加环素对鲍曼不动杆菌敏感性的比较[J].中华检验医学杂志,2013,36(7):598-603. 被引量:22
  • 10张冀霞,赵春江,刘文云,严薇,彭秋生,王占伟,王辉.替加环素对鲍曼不动杆菌和肺炎克雷伯菌体外抗菌活性检测的影响因素和方法学评估[J].中华检验医学杂志,2013,36(7):604-609. 被引量:23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部